AltMountain

Avant Bio Fund II LP

New York, NY · CIK 1972528 · Managed by Avant Bio LLC

Avant Bio Fund II LP is a venture capital fund based in New York, New York. According to its most recent Form D, filed Dec 23, 2024, it has sold $57,450,000 of interests to 12 investors since its first sale in May 2023. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Daniella Kranjac.

Total raised
$57,450,000Cumulative sales reported on Form D
Investors
12
First sale
May 12, 2023
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Daniella Kranjac
Latest Form D
Dec 23, 2024

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌‌⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Dec 23, 2024Form D/A (amendment)$57,450,00012SEC.gov ↗
Aug 18, 2023Form D$36,950,00010SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Aug 18, 2023. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Avant Bio Fund II LP

What is the minimum investment for Avant Bio Fund II LP?

Avant Bio Fund II LP's latest Form D, filed Dec 23, 2024, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Avant Bio Fund II LP?

Avant Bio Fund II LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Avant Bio Fund II LP raised?

Avant Bio Fund II LP reports $57,450,000 sold from 12 investors on its Form D filed Dec 23, 2024. This is cumulative sales since the offering began, not current assets or performance.

Where is Avant Bio Fund II LP based?

Avant Bio Fund II LP is based in New York, New York and is managed by Avant Bio LLC.

When did Avant Bio Fund II LP launch?

Avant Bio Fund II LP reports its first sale in May 2023.

Size compared with every venture capital fund

Raised more than 93% of the 1,243 venture capital funds based in New York, and more than 97% of all 14,876 that report sales.

More venture capital funds in New York

Similar-size venture capital funds in New York

All venture capital funds in New York